ENVI - Exchange of views with Emer Cooke, Executive Director of the European Medicines Agency (EMA)

COVI Special Committee - Exchange of views with Emer Cooke, Executive Director of the European Medicines Agency (EMA)

ENVI Committee - Exchange of views with Emer Cooke, Executive Director of the European Medicines Agency (EMA)

ENVI Committee - Exchange of views with  Emer Cooke,EMA Executive Director, on the update of evaluation and authorisation of COVID-19 vaccines

ENVI -  Committee on the Environment, Public Health and Food Safety - State of play with the assessment and authorization of vaccines against COVID-19 - Exchange of views with Emer COOKE, Executive Director of the European Medicines Agency (EMA)

This infoclip shows how the European Parliament responded to COVID pandemic from March 2020 with distancing activities of the European Parliament held by David SASSOLI, EP President until the press conference to present the results of the work of the Committee on collecting the evidence and lessons learned from the COVID-19 pandemic as well as to give answers on the impact it had on citizens and their fundamental rights, the businesses, the health sector and international community in June 2023. This infoclip shows illustrations of EP buildings used in the fight against COVID-19, the Green corridor at the Belgium-Dutch border, digital COVID certificates, trilogue on the EU COVID-19 certificate, meetings of the Special COVI Committee, vaccines production and distribution, COVID-19 pandemic: lessons learned and recommendations for the future.

European Parliament’s priorities and achievements (2019-2024): Response to COVID pandemic

From 2020 to 2022, the European Union has faced a public health threat with the COVID-19 pandemic. On 10 March 2022, the European Parliament established a new special committee on the COVID-19 pandemic, composed of 38 members. After more than a year of work, the final report is voted and presents its recommendations for the future, based on the lesson learned. This clip illustrates two years of pandemic through footages of lockdowns, testings, masks distributions, vaccinations, digital certificates but also comes back on the work of the COVI Committee with extracts of past meetings.

Memoclip: COVID-19 pandemic - lessons learned and recommendations for the future

MEPs from the COVI Committee (Special Committee on the COVID-19 pandemic: lessons learned and recommendations for the future) exchange with Stella KYRIAKIDES, Commissioner for Health, Food and Safety Commissioner on new regulation on cross-border threats to health, a new EU network of reference laboratories, the long-Covid side effects and the transparency around vaccines contracts. In a second part, they exchange with Emer COOKE, Executive Director of the European Medicines Agency on the recommendations to strengthen EMA’s response to future public health emergencies. Extracts.

Exchange of views with Stella KYRIAKIDES, European Commissioner for Health and Food Safety and with Emer COOKE, Executive Director of the European Medicines Agency (EMA): extracts - COVI Committee

The Executive Director of the European Medicines Agency (EMA), Emer Cooke debates with the members of the Environment and Public Health Committee the latest developments in the COVID-19 vaccination campaign (including reviews, authorisations for paediatric use and boosters), as well as recent developments around COVID-19 therapeutics and the general epidemiological situation

Exchange of views with Emer COOKE, Executive Director of the European Medicines Agency (EMA) - ENVI Committee: Exchange of views

Members of the EP Committee on the Environment, Public Health and Food Safety exchange with Emer COOKE, Executive Director of the European Medicines Agency (EMA). Emer COOKE stressed that people will need to extend the protection againt COVID with a booster again, especially with the threat of the new variant Omicron. Some MEP's pointed out that citizens have the right to be informed and to have access to the clinical trial data.

Exchange of views with Emer COOKE, Executive Director of the European Medicines Agency (EMA): Extracts - ENVI Committee

Exchange of views with Emer COOKE, Executive Director of the European Medicines Agency (EMA) - ENVI Committee: Opening statements

Emer COOKE, European Medicines Agency (EMA) Executive Director update MEPs from the Environment, Public Health and Food Security Committee on the state of play in the evaluation and market authorisation of vaccines against COVID-19 and the next steps. And Members of the Budgets Control Committee and the Commission’s Director-General for Health and Food Safety (SANTE), Sandra GALLINA, discuss the current state of the EU’s advance purchase agreement on vaccines against COVID-19.

Update of purchase, evaluation and authorization of COVID-19 vaccines: extracts from the exchanges of views with Sandra GALLINA, Director-General of DG SANTE (CONT) and with Emer COOKE, EMA Executive Director (ENVI)

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) exchange views on the update of evaluation and authorization of COVID-19 vaccines, with Emer COOKE, Executive Director of the European Medicines Agency's (EMA), in the European Parliament in Brussels. Questions & answers

Update of evaluation and authorization of COVID-19 vaccines - Exchange of views with Emer COOKE, EMA Executive Director: questions & answers

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) exchange views on the update of evaluation and authorization of COVID-19 vaccines, with Emer COOKE, Executive Director of the European Medicines Agency's (EMA), in the European Parliament in Brussels. Opening statements by Pascal CANFIN, ENVI Chair, and Emer COOKE. This transcription speech is the result of an automatic process. Check against delivery.

Update of evaluation and authorization of COVID-19 vaccines - Exchange of views with Emer COOKE, EMA Executive Director: opening statements by Pascal CANFIN, ENVI Chair, and Emer COOKE

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) exchange views on the update of evaluation and authorization of COVID-19 vaccines, with Emer COOKE, Executive Director of the European Medicines Agency's (EMA), in the European Parliament in Brussels. Closing statements by Pascal CANFIN, ENVI Chair, and Emer COOKE.

Update of evaluation and authorization of COVID-19 vaccines - Exchange of views with Emer COOKE, EMA Executive Director: closing statements by Pascal CANFIN, ENVI Chair, and Emer COOKE

Emer COOKE, Executive Director of the European Medicines Agency, answers questions posed by the members of the Committee on the Environment, Public Health and Food Safety on vaccine authorisation, availability and deployment.

Exchange of views with Emer COOKE, Executive Director of the European Medicines Agency EP Committee on the Environment, Public Health and Food Safety: questions/answers with the MEPs

Emer COOKE, Executive Director of the European Medicines Agency, exchanges with the members of the Committee on the Environment, Public Health and Food Safety on vaccine authorisation, availability and deployment .

Exchange of views with Emer COOKE, Executive Director of the European Medicines Agency EP Committee on the Environment, Public Health and Food Safety: opening statement

Members of the Committee on the Environment, Public Health and Food (ENVI) of the European Parliament, exchange with Emer COOKE, Executive Director of the European Medicines Agency (EMA) on vaccine authorisation, availability and deployment. Statements by Peter LIESE (EPP, DE), and Jytte GUTELAND (S&D, SE).

Exchange of views with Emer COOKE, Executive Director of the European Medicines Agency: extracts

In 2020, the coronavirus pandemic has put European health systems under enormous pressure and gaps have been showed up in the way public health emergencies are addressed. The EU is working on how to secure access to COVID-19 vaccines for all and the Parliament supported speedy authorisation of safe vaccines. Also, MEPs paved the way for an effective EU health programme, called "EU4Health" (for 2021-2027), which aims to fill these gaps. EU4Health's three main priorities are: tackling cross-border health threats; making medicines available and affordable; and strengthening health systems.

European Parliament Review 2020 - EU response to COVID-19

The Committee on the Environment, Public Health and Food Safety (ENVI) discuss the state of play on assessing and authorising vaccines against COVID-19 with Emer COOKE, Executive Director of the European Medicines Agency (EMA), in the European Parliament in Brussels.

15 rezultate